Oil Continues to Take a Beating
In a slowing economy, energy demand is beginning to dip dangerously low, as trading on Thursday saw the price of…
Blog
Dow Extends Losses on Economic Skepticism
For the second day in a row, the Dow Jones Industrial Average plummeted several hundred points as weary investors continue…
Performance Health Technologies, Inc. (PFMH.OB) Attracts More Attention from the Media, Including Scientific American’s News Blog
Today, Performance Health Technologies announced that its proprietary Core:Tx® rehabilitation product was featured in the September 5 edition of Scientific…
Artfest International Inc. (ARTI.OB) Says Market Undervalues its Shares and Announces Plan to Repurchase its Common Stock
Recently, we reported that Artfest was “One to Watch.” We continue with that thought, as today Artfest International Inc. (Artfest)…
QuoteMedia, Inc. (QMCI.OB) Management is Leading the Way
QuoteMedia has become the renowned leader in providing market coverage of all North American Exchanges and ECN’s including common stock,…
Cambridge Heart Inc. (CAMH.OB) Maintains Confidence Despite Weak Q3 Results
Cambridge Heart Inc. (OTCBB: CAMH) develops and commercializes non-invasive product used for diagnosing cardiac disease, focusing on the identification of…
ECOtality, Inc. (ETLY.OB) Encouraged by Obama’s Clean Energy Policy
ECOtality, Inc., a leader in clean electric transportation and storage technologies, expressed optimism today about President-elect Obama’s comprehensive energy plan,…
Brite-Strike Tactical Illumination Products, Inc. (BSTI.PK) Featured in Frontgate Christmas Catalog
Brite-Strike Tactical Illumination Products, Inc., makers of high-tech illumination devices for police and government use as well as for personal…
Nevada Geothermal Power Inc. (NGLPF.OB) Fixed Price Contracts Awarded and Moving Forward
In today’s rocky economic setting, it is always a refreshing event to see a project with broad economic reach progressing…
DURECT Corp. (DRRX) Announces Third Quarter Financial Results; CEO Comments on Outlook for REMOXY®
DURECT Corporation (NASD: DRRX), an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, recently reported…